We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Invasive Stroke Prevention Risky for Women

By HospiMedica staff writers
Posted on 21 Feb 2005
Although doctors have been criticized for not treating cardiovascular disease as aggressively in women as in men, new data suggest that women may actually be treated too aggressively.

A standard test is used to assess when the risk of a stroke outweighs the risk of preventive treatments, which include surgery and nonsurgical placement of a stent. More...
Usually, this test is interpreted in the same manner for both men and women. This leads to a potential overestimation of a woman's risk of stroke, researchers have found.

Duplex ultrasound, involving a Doppler probe, is the test most often used to assess carotid artery narrowing, which translates into the risk of stroke. This method measures how fast the blood is flowing through the artery. Fast blood implies the artery is narrowed, and the more quickly it is flowing, the worse the blockage will be. However, a women's blood tends to flow faster than men even when normal, which suggests the results should be interpreted differently for the two genders.

In a recent study, duplex ultrasound was used to analyze the most-diseased artery in 328 men and 241 women during a 10-year period. Each patient also had an arteriogram, which accurately measures the narrowing of the artery. Researchers found that blood flow in women was about 16% faster than in men on average.

"At our clinic, we treat men when duplex ultrasound shows they have a blockage of 60-70%, whereas for women, we're waiting until the duplex ultrasound suggests the blockage is about 80%,” noted Anthony Comerota, M.D., principal investigator in the study and clinical professor of surgery at the University of Michigan (Ann Arbor, USA).

According to Dr. Comerota, the difference in treatment risks and results is likely due to several factors. Women's blood vessels are smaller and less compliant than men's, making treatment riskier. Also, plaque is distributed differently in the carotid arteries of the two genders. Numerous studies have shown that using stents to open clogged leg arteries is less successful in women than in men.




Related Links:
University of Michigan

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.